EUVIMEDEUVIMED entdecken
Crossref

High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer

Chuanyong Yu, Ting Xu, Hehui Fang, Xiaoyue Wang, Na Liu, Liangfeng Yang, Shencun Fang

Journal of Neuro-Oncology · 2024-08 · 169 (1) · 203-213

DOI: 10.1007/s11060-024-04716-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 25.06.2024. Verfasst von Chuanyong Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: ErbB Receptors, Lung Neoplasms, Salvage Therapy, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsLung NeoplasmsSalvage TherapyCarcinoma, Non-Small-Cell LungHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsExonsAdultMutationMeningeal NeoplasmsMeningeal CarcinomatosisFollow-Up StudiesPrognosisMutagenesis, Insertional

Stichwörter der Autor:innen

EGFR ex20insFurmonertinibIntraventricular chemotherapyLeptomeningeal metastasisNSCLC

Substanzen

ErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Department of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Respiratory Medicine, Nanjing Chest Hospital, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Respiratory Medicine, Nanjing Gaochun People's Hospital, Nanjing, China.
  • Department of Respiratory Medicine, Nanjing Chest Hospital, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China. fang1984@aliyun.com.

Zitieren

APA

Yu, C., Xu, T., Fang, H., Wang, X., Liu, N., Yang, L., & Fang, S. (2024). High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer. Journal of Neuro-Oncology, 169(1), 203-213. https://doi.org/10.1007/s11060-024-04716-0

Vancouver

Yu C, Xu T, Fang H, Wang X, Liu N, Yang L, et al. High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer. Journal of Neuro-Oncology. 2024;169(1):203-213. doi:10.1007/s11060-024-04716-0

BibTeX
@article{Yu2024,
  author = {Yu, Chuanyong and Xu, Ting and Fang, Hehui and Wang, Xiaoyue and Liu, Na and Yang, Liangfeng and Fang, Shencun},
  title = {High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  volume = {169},
  number = {1},
  pages = {203--213},
  doi = {10.1007/s11060-024-04716-0}
}
Kostenlos starten →